Anzeige
Mehr »
Dienstag, 31.03.2026 - Börsentäglich über 12.000 News
Globaler Roll-out startet: Explosives Update: CA$8,4 Mio. Auftragsbestand - Nexus rollt Europa & Arktis auf
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 873997 | ISIN: US2939041081 | Ticker-Symbol: EZ1
Stuttgart
30.03.26 | 15:16
0,001 Euro
0,00 % 0,000
1-Jahres-Chart
VISKASE HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
VISKASE HOLDINGS INC 5-Tage-Chart

Aktuelle News zur VISKASE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoViskase Holdings, Inc. - 8-K, Current Report2
MiEnzon Pharmaceuticals, Inc: Enzon Announces Completion of the Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock3
VISKASE Aktie jetzt für 0€ handeln
24.03.Enzon Pharmaceuticals executes 1-for-100 reverse stock split ahead of merger3
24.03.Enzon Pharmaceuticals, Inc: Enzon Announces Reverse Stock Split312CRANFORD, N.J., March 24, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) ("Enzon" or the "Company"), today announced that the previously approved 1-for-100 reverse stock split...
► Artikel lesen
24.03.ENZON PHARMACEUTICALS, INC. - 8-K, Current Report2
16.03.Enzon Pharmaceuticals, Inc: Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock1
16.03.ENZON PHARMACEUTICALS, INC. - 8-K, Current Report-
09.03.Enzon Pharmaceuticals, Inc: Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock4
09.03.ENZON PHARMACEUTICALS, INC. - 8-K, Current Report1
02.03.ENZON PHARMACEUTICALS, INC. - 10-K, Annual Report-
27.02.Enzon Pharmaceuticals, Inc: Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock2
27.02.ENZON PHARMACEUTICALS, INC. - 8-K, Current Report1
11.02.ENZON PHARMACEUTICALS, INC. - 8-K, Current Report1
30.01.Enzon Pharmaceuticals, Inc: Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger121CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) ("Enzon" or the "Company"), today announced that it has commenced an exchange offer (the "Offer") involving...
► Artikel lesen
30.01.ENZON PHARMACEUTICALS, INC. - S-4/A, Registration of securities, business combinations1
30.01.ENZON PHARMACEUTICALS, INC. - 8-K, Current Report1
28.01.ENZON PHARMACEUTICALS, INC. - S-4, Registration of securities, business combinations2
23.12.25ENZON PHARMACEUTICALS, INC. - 8-K, Current Report-
12.11.25ENZON PHARMACEUTICALS, INC. - 10-Q, Quarterly Report-
24.10.25Enzon Pharmaceuticals and Viskase amend merger agreement with revised ownership terms1
Weiter >>
23 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1